Ortho Clinical Diagnostics Holdings plc
OCDXDelisted May 27, 2022- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001828443
Ortho Clinical Diagnostics Holdings plc was delisted on May 27, 2022; its insiders filed their last Form 4 on Jun 1, 2022; 170 institutions reported holding it in 13F filings for Q1 2022, worth $4.38B in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Ortho Clinical Diagnostics Holdings plc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +12 vs. Q1 2021
- Shares held
- 231.9M
- −1.09M (−0.5%) vs. Q1 2021
- Total value
- $4.95B
- +$457.1M (+10.2%) vs. Q1 2021
- New holders
- 28
- 36 more added
- Sold out
- 16
- 36 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $1.00K |
| Q2 2022 | 1 | $1.00K |
| Q1 2022 | 170 | $4.38B |
| Q4 2021 | 162 | $5.01B |
| Q3 2021 | 140 | $4.31B |
| Q2 2021 | 106 | $4.95B |
| Q1 2021 | 95 | $4.52B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Ortho Clinical Diagnostics Holdings plc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shapiro Capital Management LLC | 5,566,581 | $119.2M | 2.07% | +1,457,515+35.5% | Added |
| BlackRock Inc. | 6,133,317 | $131.3M | 0.00% | −437,491−6.7% | Reduced |
| Janus Henderson Group PLC | 6,364,925 | $136.3M | 0.06% | −721,162−10.2% | Reduced |
| Vanguard Group Inc | 7,832,221 | $167.7M | 0.00% | +232,353+3.1% | Added |
| Price T Rowe Associates Inc | 15,796,863 | $338.2M | 0.03% | −74,725−0.5% | Reduced |
| Carlyle Group Inc. | 143,406,000 | $3.07B | 20.78% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,352,941−100.0% | Sold out |
| Anchorage Capital Group, L.L.C. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −413,891−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −210,267−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −130,606−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −62,667−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −37,400−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −25,101−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −21,200−100.0% | Sold out |
| Rit Capital Partners PLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −16,615−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −5,140−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,549−100.0% | Sold out |
| Plante Moran Financial Advisors, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Waddell & Reed Financial Inc | – | – | – | – | Not filed |